• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Cosmetic Raw Material
  • Pharmaceutical IntermediatesPharmaceutical intermediates Nutritional Supplements Pharmaceutical raw materials
  • OEM & ODMCapsule Softgel Capsule Gummies Drop & drinks Tables
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Anthelmintics Antiviral drugs Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Oxaliplatin CAS 61825-94-3 Raw Materials Powder

    • Oxaliplatin CAS 61825-94-3 Raw Materials Powder
    • Oxaliplatin CAS 61825-94-3 Raw Materials Powder
    • Oxaliplatin CAS 61825-94-3 Raw Materials Powder storehouse
    • Oxaliplatin CAS 61825-94-3 Raw Materials Powder quality testing
    • Oxaliplatin CAS 61825-94-3 Raw Materials Powder quality testing
    • Oxaliplatin CAS 61825-94-3 Raw Materials Powder certificate

    Product Overview:

    Oxaliplatin CAS 61825-94-3 is a white powder solid, a platinum-based antitumor drug commonly used to treat colorectal cancer. It inhibits the growth and division of cancer cells by interfering with DNA replication and repair.Oxaliplatin Raw Materials is often used with other chemotherapeutic agents such as 5-fluorouracil and calcium folinate.Oxaliplatin Powder is clinically used to treat patients with metastatic colorectal cancer after failure of fluorouracil therapy.It can be given by administered intravenously and usually needs to be given in a hospital or clinic.

    Oxaliplatin CAS 61825-94-3 Raw Materials Powder Attributes

    Product Name: Oxaliplatin CAS 61825-94-3 Raw Materials Powder

    CAS: 61825-94-3

    MF: C8H12N2O4Pt

    Oxaliplatin Powder

    Specification​: 99% min Oxaliplatin Powder

    Sample: Oxaliplatin Powder

    Brand: Henrikang

    Appearance: White Powder

    Storage: Cool Dry Place

    Shelf Life: 2 Years

    Test Method: HPLC

    Portal:https:https://henrikang.en.made-in-china.com/

    Oxaliplatin CAS 61825-94-3 Raw Materials Powder Details

    Oxaliplatin Powder Usage and Synthesis :

    Oxaliplatin, also known as Loxadine and oxalate platin, is a platinum derivative. It is clinically used for the treatment of patients with colorectal cancer metastasis after the failure of fluorouracil treatment. It can be used alone or in combination with fluorouracil.

    Oxaliplatin CAS 61825-94-3 is a white powder solid,  a platinum-based antitumor drug commonly used to treat colorectal cancer. It inhibits the growth and division of cancer  cells by interfering with DNA replication and repair.Oxaliplatin Raw Materials is often used with other chemotherapeutic  agents such as 5-fluorouracil and calcium folinate.Oxaliplatin Powder is clinically used to treat patients with  metastatic colorectal cancer after failure of fluorouracil therapy.It can be given by administered intravenously and  usually needs to be given in a hospital or clinic.

    Oxaliplatin Powder

    Application/Function of Oxaliplatin Powder .

    The principle of action is to inhibit DNA synthesis and replication by producing alkylated conjugates that act on DNA, forming intra- and interstrand cross-links. It also inhibits the proliferation of ovarian cancer and melanoma cell lines.

    Oxaliplatin is a commonly used antitumor drug, also known as platinum oxide. It is a white crystalline powder with the chemical formula C15H24N2O2Pt and a molecular weight of 397.3. Oxaliplatin belongs to the platinum family of compounds and is a derivative of a platinum compound with higher antitumor activity and lower toxicity than other platinum compounds.

    Oxaliplatin Powder

    The mechanism of action of oxaliplatin is to inhibit the proliferation and spread of tumor cells by binding to DNA and preventing DNA replication and repair of tumor cells. In addition, oxaliplatin can also induce apoptosis in tumor cells, thereby promoting tumor therapeutic effects.

    Production method of Oxaliplatin Powder .

    Oxaliplatin is mainly used for the treatment of ovarian cancer, lung cancer, gastric cancer, colorectal cancer and other malignant tumors. It is usually used in combination with other chemotherapeutic drugs to improve the therapeutic effect. In clinical application, oxaliplatin is usually administered as an intravenous injection, with the dose and dosing regimen depending on the patient's physical condition and tumor type.

    Adverse effects of oxaliplatin mainly include bone marrow suppression, nausea, vomiting, diarrhea, mouth ulcers, and skin irritation. When using oxaliplatin, patients' vital signs and hematological indicators should be closely monitored and adverse reactions should be dealt with in a timely manner.

    Oxaliplatin Powder Factory

    The following points need to be noted for the storage and use of oxaliplatin:

    1.  Oxaliplatin should be stored in a dry, cool and ventilated place, avoiding direct sunlight and high temperature.
    2.  The appearance and quality of oxaliplatin should be checked before use, and if any foreign substance or deterioration is found, it should be stopped immediately.
    3. When using oxaliplatin, appropriate safety measures should be taken to avoid contact with skin and inhalation of gas to avoid adverse reactions.
    4. Medical personnel using oxaliplatin should receive relevant training and instruction to master the correct usage and precautions.

    Oxaliplatin Powder Package

    In conclusion, oxaliplatin is a commonly used antitumor drug with high antitumor activity and low toxicity. In clinical application, it should be used rationally according to the patient's physical condition and tumor type, closely monitor the patient's vital signs and hematological indices, and promptly deal with adverse reactions in order to achieve the best therapeutic effect.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,